The present invention provides a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject using a compound of the present invention or a pharmaceutically acceptable salt thereof and a method of inhibiting mutant C-KIT induction Lt; RTI ID = 0.0 cell proliferative / RTI disorder (s).
展开▼